The Contribution of Changes in Drug Mix and Price Growth to the Rising Costs of Brand-Name Drugs in Medicare Part D

Congressional Budget Office (CBO)

This government document is issued by Congressional Budget Office (CBO) for use in U.S.

Add to Favorites
File Details: PDF (274 KB)
Downloads: 30
Source
https://www.cbo.gov/system/files/2022-03/57699-APPAM.pdf

Have Questions About This Form?
Ask An Expert For Help:

Questions and comments are moderated. Minimum of 10 characters.

All questions and comments are moderated and publicly viewable. Please do not post private or sensitive information such as names, addresses, phone numbers, emails, confidential financial and legal details.

Login or sign up to submit questions